1. Ertugliflozin in type 2 diabetes: a profile of its use

   • Lesley J. Scott

   Adis Drug Q&A 03 July 2019 Pages: 351 - 362

2. Human α₁-proteinase inhibitor (Respreeza^®) in α₁-antitrypsin deficiency emphysema: a profile of its use in the EU

   • Hannah A. Blair

   Adis Drug Q&A 24 June 2019 Pages: 363 - 368

3. When managing ulcerative colitis in older patients, understanding their overall health profile is key

   • Adis Medical Writers

   Disease Management 14 June 2019 Pages: 369 - 373

4. First reports of adverse drug reactions

   Drug Reactions and Interactions 04 July 2019 Pages: 374 - 375

5. Identify potentially inappropriate medications in older adults with chronic kidney disease and deprescribe when possible

   • Adis Medical Writers

   Practical Issues and Updates 22 May 2019 Pages: 376 - 380

   

6. Intravenous medication errors in Selangor, Malaysia: prevalence, contributing factors and potential clinical outcomes

   • Josephine Henry Basil
   • Jern Ni Wong
   • Devi Shantini Rata Mohan

   Original Research Article 15 May 2019 Pages: 381 - 390

   

7. The off-label use of medicines in pediatric outpatients in Bulgaria based on an analysis of their prescription data

   • Maria Drenska
   • V. Grigorova
   • I. Getov

   Original Research Article 22 May 2019 Pages: 391 - 395

8. Management and evaluation of treatment adherence and effectiveness in chronic venous disorders: results of the international study VEIN Act Program

   • Vadim Bogachev
   • José Manuel Jiménez Arribas
   • Andres Marin

   Original Research Article Open access 27 May 2019 Pages: 396 - 404